Loading...
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
INTRODUCTION: Alzheimer’s disease (AD) is increasing in frequency as the global population ages. Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist. We have an urgent need to find new therapies for AD. METHODS:...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4095696/ https://ncbi.nlm.nih.gov/pubmed/25024750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt269 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|